ccinfoadmin Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Kunvara Orachon, Watcharapa Jaranasaksakul, Preyaporn Onsod, Teerapong Siriboonpiputtana, Budsaba Rerkamnuaychoke, Takol Chareonsirisuthigul
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Kaiduo Xu, Yunmiao Sun, Xuanchang Bai, Jing Wang, Jiangtao Zhang, Haijian Zhao, Weiyan Zhou, Chuanbao Zhang
Clin Chem Lab Med. 2026 Aug 6. doi: 10.1515/cclm-2026-0428. Online ahead of print. ABSTRACT OBJECTIVES: Therapeutic drug monitoring (TDM) of meropenem is critical for optimizing clinical efficacy and minimizing toxicity. We describe the validation of an isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) candidate reference measurement procedure (RMP) for the quantification of meropenem in human serum … Read more
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Zixia Wang, Xiaozhong Chen, Huiqiong Lu, Qianyun Deng, Liuqin Chen, Yue Meng, Beibei Wang, Lei Wang, Wei Fang
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Martin Safran, James Corines, Matthew Elkins, Michel R. Nasr, Katalin Banki, Zhimin Tim Cao
Clin Chem. 2026 Aug 5:hvag089. doi: 10.1093/clinchem/hvag089. Online ahead of print. ABSTRACT INTRODUCTION: Noninvasive cell-free DNA (cfDNA) metagenomic sequencing enables hypothesis-free detection of microbial pathogens in patients with suspected infections. However, its clinical sensitivity is often limited by the overwhelming background of host-derived cfDNA, which can obscure low-abundance microbial signals. We developed an epigenetically guided … Read more
Clin Chem. 2026 Aug 3:hvag094. doi: 10.1093/clinchem/hvag094. Online ahead of print. ABSTRACT BACKGROUND: Familial dysbetalipoproteinemia (FDB) is a genetic lipoprotein disorder that can develop in patients homozygous for the apolipoprotein 2 (APOE2) genotype (APOE ɛ2/ɛ2). It is associated with decreased clearance of remnant lipoproteins and increased atherosclerotic cardiovascular disease (ASCVD) risk disproportionate to low-density lipoprotein-cholesterol … Read more
Clin Chem. 2026 Aug 3;72(8):830. doi: 10.1093/clinchem/hvag073. NO ABSTRACT PMID:42545161 | DOI:10.1093/clinchem/hvag073
Clin Chem. 2026 Aug 3;72(8):911. doi: 10.1093/clinchem/hvag049. NO ABSTRACT PMID:42545160 | DOI:10.1093/clinchem/hvag049
Clin Chem. 2026 Aug 3;72(8):828-829. doi: 10.1093/clinchem/hvag065. NO ABSTRACT PMID:42545159 | DOI:10.1093/clinchem/hvag065
